• EN/ES

    Womens Health

    WebHealthNetwork : 2,378,479

  • Benefits & Savings
  • : Primary Biliary Cholangitis

Primary Biliary Cholangitis - 11 Studies Found

RECRUITING : IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
: Primary Biliary Cholangitis
: 2024-11-21
: Seladelpar 10 mg one capsule daily for up to 52 weeks
<<< Previous
Womens Health Care
Womens Health Care WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • Weighthealthcenter
  • CosmeticAndPlasticSurgeryCenter
  • FarmingResourceCenter
  • LivestockHealthcare
  • PetsFirstHealth
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Womens Health Care.

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.